ResearcherUniversità Cattolica del Sacro CuoreNo recent work listed
Carlo Antonio Barone
Matched on ORCID iD 0000-0002-2375-2016; OpenAlex author ID A5012446712. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper
Papers 4
- An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the… First author DOI 10.1080/14737167.2018.1464394↗
- RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer. Co-author DOI 10.21873/invivo.11136↗
- Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse. Last author DOI 10.1007/s12094-015-1471-z↗
- A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer. First author DOI 10.1093/annonc/mdu205↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Evaristo Maiello · 1 shared paper, 2018 · strength 0.08
- Carlo R. Lazzaro · 1 shared paper, 2018 · strength 0.08
- Giampaolo Tortora · 1 shared paper, 2018 · strength 0.08
- Michèle Milella · 1 shared paper, 2018 · strength 0.08
- Michele Reni · 1 shared paper, 2018 · strength 0.08
- Stefano Cascinu · 1 shared paper, 2018 · strength 0.08
- Giovanni Schinzari · 1 shared paper, 2017 · strength 0.06
- Gian Carlo Mattiucci · 1 shared paper, 2017 · strength 0.06
- Ernesto Rossi · 1 shared paper, 2017 · strength 0.06
- Guido Rindi · 1 shared paper, 2017 · strength 0.06
- Armando Orlandi · 1 shared paper, 2016 · strength 0.05
- Edward Wang · 1 shared paper, 2014 · strength 0.04
- Francesco Leone · 1 shared paper, 2014 · strength 0.04
- Massimo Aglietta · 1 shared paper, 2014 · strength 0.04
- Michael B. Sawyer · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.